性(Sex)CELL: stem cell care for menopausal vaginal dryness and incontinence

Cheongdam Cell Clinic states that after menopause, declining oestrogen levels cause vaginal tissue to thin and become drier, leading to pain during intercourse. Over time, this can contribute to reduced sexual interest (frigidity) and affect quality of life within a relationship.

The principle behind 性CELL in women is injecting the patient's own bone-marrow stem cells directly into vaginal tissue. The clinic states the stem cells help increase natural lubrication, bringing sexual sensation and satisfaction closer to a younger state. The clinic also cites an effect in helping ease urinary incontinence.

Urinary incontinence in menopausal women is often linked to pelvic floor muscles and periurethral tissue weakening with age and hormonal change. The clinic states 性CELL may help ease this in some cases, but does not disclose the deeper mechanism or which severity levels respond best, so a physician should assess severity before deciding.

Medically, vaginal dryness and incontinence at menopause have several treatment routes — local oestrogen therapy, lubricants, pelvic floor (Kegel) exercises, or vaginal laser procedures. Stem cell treatment is another option some clinics have begun offering, but should be weighed alongside standard approaches that carry more established evidence.

As with the clinic's other programmes, the stem cells used are autologous, drawn from the patient's own bone marrow without a culturing step. The clinic states the entire process, from bone marrow collection to vaginal injection, can be completed within half a day, suiting Thai patients planning a short treatment trip.

The clinic gives the general caution that swelling, bleeding or infection at the injection site may occur in some cases. Since this area is delicate and prone to infection, patients should choose a facility with clear sterile-technique standards and disclose gynaecological history — such as past infections or prior surgery — to the physician beforehand every time.

Academic evidence on using stem cells for menopausal vaginal dryness and incontinence is still developing, and there is no conclusion as widely accepted as standard treatments such as local hormone therapy. Patients should consult both a gynaecologist and the treating physician to weigh the most suitable option for themselves.

Thai patients interested in this 性CELL programme should prepare gynaecological history and symptoms — time since menopause, severity of dryness or incontinence — so physicians at Cheongdam Cell Clinic can assess accurately, and should ask directly about post-procedure follow-up, since the official site does not disclose these details publicly.